PURPOSE: To evaluate the effectiveness of pars plana implants in the treatment of neovascular glaucoma. PATIENTS AND METHODS: Twenty-two consecutive pars plana implant procedures performed for neovascular glaucoma were retrospectively reviewed. RESULTS: Preoperative intraocular pressures ranged from 22 to 80 mmHg (mean 46 mmHg) on a mean of three glaucoma medications. With a mean follow-up interval of 16 months, final postoperative intraocular pressures ranged 9-21 mmHg (mean 16) on a mean 0.7 medications. One patient required a second implant to achieve final intraocular pressure control. Visual acuity was stabilized or improved in 19 of 22 cases (86%). Complications included retinal detachment in two cases (9%). Macular pucker, vitreous hemorrhage, hyphema, choroidal hemorrhage, diplopia, and loss of light perception occurred in one case (5%) each. None developed phthisis bulbi. CONCLUSION: Pars plana drainage tube implants are effective in the treatment of neovascular glaucoma.
PURPOSE: To evaluate the effectiveness of pars plana implants in the treatment of neovascular glaucoma. PATIENTS AND METHODS: Twenty-two consecutive pars plana implant procedures performed for neovascular glaucoma were retrospectively reviewed. RESULTS: Preoperative intraocular pressures ranged from 22 to 80 mmHg (mean 46 mmHg) on a mean of three glaucoma medications. With a mean follow-up interval of 16 months, final postoperative intraocular pressures ranged 9-21 mmHg (mean 16) on a mean 0.7 medications. One patient required a second implant to achieve final intraocular pressure control. Visual acuity was stabilized or improved in 19 of 22 cases (86%). Complications included retinal detachment in two cases (9%). Macular pucker, vitreous hemorrhage, hyphema, choroidal hemorrhage, diplopia, and loss of light perception occurred in one case (5%) each. None developed phthisis bulbi. CONCLUSION: Pars plana drainage tube implants are effective in the treatment of neovascular glaucoma.
Authors: Thalmon R Campagnoli; Sung Soo Kim; William E Smiddy; Steve J Gedde; Donald L Budenz; Richard K Parrish; Paul F Palmberg; William Feuer; Wei Shi Journal: Int J Ophthalmol Date: 2015-10-18 Impact factor: 1.779
Authors: Manuel Diaz-Llopis; David Salom; Salvador García-Delpech; Patricia Udaondo; Jose Maria Millan; J Fernando Arevalo Journal: Clin Ophthalmol Date: 2010-05-06